Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

Appointment of Non-Executive Director

 

19 August 2020

 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Mr Myles does not hold any interests in any of the Company's shares.

 

 

Aberdeen Standard Capital International Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKCBBDBKDNFD
Date   Source Headline
20th Sep 202211:55 amRNSNet Asset Value(s)
16th Sep 20221:42 pmRNSFourth Interim Dividend
16th Sep 202212:20 pmRNSNet Asset Value(s)
15th Sep 20221:11 pmRNSNet Asset Value(s)
15th Sep 202211:40 amRNSPortfolio disclosure
14th Sep 202212:42 pmRNSNet Asset Value(s)
13th Sep 202212:20 pmRNSNet Asset Value(s)
12th Sep 20221:58 pmRNSGearing disclosure
12th Sep 202212:29 pmRNSNet Asset Value(s)
9th Sep 202212:51 pmRNSNet Asset Value(s)
8th Sep 202212:31 pmRNSNet Asset Value(s)
7th Sep 202212:26 pmRNSNet Asset Value(s)
7th Sep 202210:05 amRNSMonth End Net Asset Value(s)
6th Sep 202212:37 pmRNSNet Asset Value(s)
5th Sep 20226:03 pmRNSGearing disclosure
5th Sep 202212:18 pmRNSNet Asset Value(s)
2nd Sep 20223:13 pmRNSQuarterly disclosure
2nd Sep 20221:25 pmRNSNet Asset Value(s)
1st Sep 20228:39 amRNSEdison update on abrdn Latin American Income Fund
31st Aug 202212:33 pmRNSNet Asset Value(s)
30th Aug 20225:14 pmRNSGearing disclosure
30th Aug 202212:31 pmRNSNet Asset Value(s)
26th Aug 202212:28 pmRNSNet Asset Value(s)
25th Aug 202211:43 amRNSNet Asset Value(s)
24th Aug 202212:42 pmRNSNet Asset Value(s)
23rd Aug 202212:57 pmRNSNet Asset Value(s)
22nd Aug 202212:58 pmRNSGearing disclosure
22nd Aug 202211:29 amRNSNet Asset Value(s)
19th Aug 202212:06 pmRNSNet Asset Value(s)
18th Aug 202211:41 amRNSNet Asset Value(s)
17th Aug 202212:38 pmRNSNet Asset Value(s)
16th Aug 202211:37 amRNSNet Asset Value(s)
15th Aug 20221:49 pmRNSGearing disclosure
15th Aug 202212:27 pmRNSNet Asset Value(s)
15th Aug 202212:03 pmRNSPortfolio disclosure
12th Aug 202211:57 amRNSNet Asset Value(s)
11th Aug 20224:23 pmRNSHolding(s) in Company
11th Aug 20221:44 pmRNSNet Asset Value(s)
10th Aug 20225:35 pmRNSHolding(s) in Company
10th Aug 202212:33 pmRNSNet Asset Value(s)
9th Aug 202212:28 pmRNSNet Asset Value(s)
8th Aug 20223:39 pmRNSGearing Disclosure
8th Aug 20222:13 pmRNSNet Asset Value(s)
5th Aug 202211:54 amRNSNet Asset Value(s)
5th Aug 202210:22 amRNSMonth End Net Asset Value(s)
4th Aug 202211:54 amRNSNet Asset Value(s)
3rd Aug 20221:11 pmRNSHolding(s) in Company
3rd Aug 202211:49 amRNSNet Asset Value(s)
2nd Aug 202212:59 pmRNSNet Asset Value(s)
1st Aug 20224:55 pmRNSGearing Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.